West Oak Capital’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-3
Closed -$505 350
2018
Q1
$505 Hold
3
﹤0.01% 339
2017
Q4
$491 Hold
3
﹤0.01% 291
2017
Q3
$615 Hold
3
﹤0.01% 326
2017
Q2
$729 Hold
3
﹤0.01% 338
2017
Q1
$717 Hold
3
﹤0.01% 361
2016
Q4
$630 Hold
3
﹤0.01% 334
2016
Q3
$691 Hold
3
﹤0.01% 368
2016
Q2
$693 Hold
3
﹤0.01% 324
2016
Q1
$804 Hold
3
﹤0.01% 260
2015
Q4
$938 Hold
3
﹤0.01% 267
2015
Q3
$815 Hold
3
﹤0.01% 274
2015
Q2
$910 Hold
3
﹤0.01% 285
2015
Q1
$893 Buy
+3
New +$855 ﹤0.01% 286

Other funds holding AGN

West Oak Capital's AGN Position: Q2 2018 in Review

West Oak Capital sold out of Allergan plc (AGN) in Q2 2018, closing a stake of 3 shares — an estimated $505 sold.

West Oak Capital first reported a position in AGN in Q1 2015 and held it in 13 quarters. The position peaked at $938 in Q4 2015. 1,043 funds tracked by Wall St. Rank hold AGN as of Q2 2018.

  • West Oak Capital reported no remaining Allergan plc position as of Q2 2018 after selling out during the quarter.
  • West Oak Capital sold 3 Allergan plc shares in Q2 2018, an estimated $505.
  • West Oak Capital first reported a position in Allergan plc in Q1 2015 and held it in 13 quarters.
  • West Oak Capital's Allergan plc position peaked at $938 in Q4 2015.
  • 1,043 funds tracked by Wall St. Rank held Allergan plc as of Q2 2018.

Based on West Oak Capital's 13F filing for Q2 2018, filed 6 Jul 2018.